These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23720247)

  • 1. Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST).
    Winchester DE; Cooper-Dehoff RM; Gong Y; Handberg EM; Pepine CJ;
    Clin Cardiol; 2013 Aug; 36(8):442-7. PubMed ID: 23720247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST).
    Sava RI; Chen YE; Smith SM; Gong Y; Cooper-DeHoff RM; Keeley EC; Pepine CJ; Handberg EM
    J Womens Health (Larchmt); 2020 Feb; 29(2):158-166. PubMed ID: 31403360
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictors of adverse outcome among patients with hypertension and coronary artery disease.
    Pepine CJ; Kowey PR; Kupfer S; Kolloch RE; Benetos A; Mancia G; Coca A; Cooper-DeHoff RM; Handberg E; Gaxiola E; Sleight P; Conti CR; Hewkin AC; Tavazzi L;
    J Am Coll Cardiol; 2006 Feb; 47(3):547-51. PubMed ID: 16458134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).
    Brunner M; Cooper-DeHoff RM; Gong Y; Karnes JH; Langaee TY; Pepine CJ; Johnson JA;
    Am J Cardiol; 2007 Jun; 99(11):1549-54. PubMed ID: 17531579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril STudy (INVEST).
    Zineh I; Cooper-Dehoff RM; Wessel TR; Arant CB; Sleight P; Geiser EA; Pepine CJ
    Clin Cardiol; 2005 Jul; 28(7):321-8. PubMed ID: 16075824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
    Magvanjav O; Gong Y; McDonough CW; Chapman AB; Turner ST; Gums JG; Bailey KR; Boerwinkle E; Beitelshees AL; Tanaka T; Kubo M; Pepine CJ; Cooper-DeHoff RM; Johnson JA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
    Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ;
    Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.
    Pepine CJ; Handberg-Thurmond E; Marks RG; Conlon M; Cooper-DeHoff R; Volkers P; Zellig P
    J Am Coll Cardiol; 1998 Nov; 32(5):1228-37. PubMed ID: 9809930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fixed combination of verapamil SR/trandolapril.
    Widimský J
    Expert Opin Pharmacother; 2000 Mar; 1(3):515-35. PubMed ID: 11249535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group.
    Messerli F; Frishman WH; Elliott WJ
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):322-7. PubMed ID: 9544873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST.
    Coca A; Messerli FH; Benetos A; Zhou Q; Champion A; Cooper-DeHoff RM; Pepine CJ
    Stroke; 2008 Feb; 39(2):343-8. PubMed ID: 18162623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort.
    Wokhlu A; Smith SM; Gong Y; Handberg EM; Elgendy IY; Bavry AA; Cooper-DeHoff RM; Pepine CJ
    J Hypertens; 2018 Feb; 36(2):419-427. PubMed ID: 28938338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2014 Eighth Joint National Committee panel recommendation for blood pressure targets revisited: results from the INVEST study.
    Bangalore S; Gong Y; Cooper-DeHoff RM; Pepine CJ; Messerli FH
    J Am Coll Cardiol; 2014 Aug; 64(8):784-93. PubMed ID: 25145522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.
    Cooper-DeHoff RM; Gong Y; Handberg EM; Bavry AA; Denardo SJ; Bakris GL; Pepine CJ
    JAMA; 2010 Jul; 304(1):61-8. PubMed ID: 20606150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
    Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
    Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease.
    Bavry AA; Kumbhani DJ; Gong Y; Handberg EM; Cooper-Dehoff RM; Pepine CJ
    J Am Heart Assoc; 2013 Aug; 2(4):e000205. PubMed ID: 23948642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of combination therapy with trandolapril and verapamil sr in primary hypertension: a 4 x 4 trial design. The Trandolapril Study Group.
    DeQuattro V; Lee D; Messerli F
    Clin Exp Hypertens; 1997 Apr; 19(3):373-87. PubMed ID: 9107443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.